Archives

by in
Entry Author Date Location
Array Biopharma Gets Rights to Second Novartis Cancer Drug 01/23/15 Boulder/Denver
Alnylam CEO: More Cash in Hand Is to Fuel Expansion From Within 01/21/15 Boston
It Had to be You: Why Roche Was The Lone Suitor For Foundation 01/16/15 Boston
West Coast Biotech Roundup: Tobira, Novartis, NantCell, & More 01/15/15 San Francisco
Qualcomm-Novartis Deal Portends Wave of Clinical Trial Innovation 01/15/15 San Diego
Qualcomm Ventures Forms Joint Investment Business with Novartis 01/12/15 San Diego
Surface Oncology Raises $35M to Develop Cancer Immunotherapies 01/08/15 Boston
CART + CRISPR = 1st-Of-Its-Kind Biotech Deal From Novartis, Intellia 01/07/15 Boston
Don’t Get Comfortable: 5 Biopharma Flashpoints to Consider in 2015 01/06/15 National
Larry Corey, Cofounder of 2014 Top Biotech Juno: “It’s No Outlier” 01/05/15 Seattle
Officials Say Fuji’s Purchase of Kalon Boosts Texas’s Biotech Profile 12/22/14 Texas
Rethinking Venture Philanthropy After the Kalydeco Windfall 12/22/14 Boston
Houston’s Bellicum Pharma Rides T-Cell Therapy Wave to $140M IPO 12/18/14 Texas
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
Immunotherapy Confidence (And Audience) Abundant At ASH T-Cell Talk 12/08/14 National
With New Data, Agios Plots Quick Turn into Key Late-Stage Trials 12/07/14 Boston
Array and Novartis End Development Deal for Cancer Drug Binimetinib 12/04/14 Boulder/Denver
More Biotechs Belly-Up These Days but Dendreon Still “One of a Kind” 12/02/14 National
With Souped-Up Rituxan, Unum Plots First Foray Into T-Cell Therapy 12/01/14 Boston
With Atlas Cash and Berkeley Tools, Intellia Joins the CRISPR Fray 11/18/14 Boston
New Research Could (Finally) Remove RNAi’s Commercial Limitations 11/17/14 National
Juno, Less Than a Year Old, Lines up IPO to Fund Cancer Work 11/17/14 Seattle
What Early Looks From ASH Tell Us About Cancer Immunotherapy 11/07/14 National
Proteostasis, Astellas Join up on Genetic Disease Drugs 11/04/14 Boston
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More 10/31/14 Boston
Aiming to Boost Innovation, Trinity Fine-Tunes Its Tech Transfer 10/30/14 National
Opsona, And Pharma Backers, Await Day of Reckoning for Kidney Drug 10/29/14 National
Pharmas, Others Bet $33M More on Aileron’s P53 Peptide Drug 10/29/14 Boston
East Coast Biotech Roundup: PureTech, Celgene, Unum, Biogen & More 10/24/14 Boston
New Atlas Startup Gets “Quartet” of Backers, $17M For Pain Drugs 10/23/14 Boston
Page 1 of 14 next page »